Junfeng Hao
Impact in
-
- SARS-CoV-2 and COVID-19 Research
-
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
Papers in
-
- Viral gastroenteritis research and epidemiology 3
- SARS-CoV-2 and COVID-19 Research 2
-
- Animal Virus Infections Studies 3
- Co-authors
- Qin Ma (1 shared paper)Taotao Wei (1 shared paper)Yaping Tu (1 shared paper)Peter W. Abel (1 shared paper)Yan Xie (1 shared paper)Linghai Li (1 shared paper)Dennis W. Wolff (1 shared paper)Peng Wei (1 shared paper)
- Journals
- Nature Communications (2 papers)iScience (1 paper)Scientific Reports (1 paper)Cell Research (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Junfeng Hao
10 papers receiving 434 citations
Peers
Comparison fields: 5 of 82
- Infectious Diseases 113
- Cancer Research 81
- Hepatology 29
- Pulmonary and Respiratory Medicine 93
- Immunology 60
Countries citing papers authored by Junfeng Hao
This map shows the geographic impact of Junfeng Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfeng Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfeng Hao more than expected).
Fields of papers citing papers by Junfeng Hao
This network shows the impact of papers produced by Junfeng Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfeng Hao. The network helps show where Junfeng Hao may publish in the future.
Co-authors
The 25 scholars most cited alongside Junfeng Hao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 126 | |
| 2 | 2018 | 97 | |
| 3 | 2014 | 85 | |
| 4 | 2021 | 56 | |
| 5 | 2021 | 25 | |
| 6 | 2022 | 23 | |
| 7 | 2022 | 19 | |
| 8 | 2025 | 4 | |
| 9 | 2023 | 3 | |
| 10 | 2021 | 3 |
About Junfeng Hao
Junfeng Hao is a scholar working on Infectious Diseases, Animal Science and Zoology, Genetics, Immunology and Pulmonary and Respiratory Medicine, having authored 10 papers that have together received 441 indexed citations. Recurring topics across this work include Animal Virus Infections Studies (3 papers), Viral gastroenteritis research and epidemiology (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Virus-based gene therapy research (2 papers), Polymer-Based Agricultural Enhancements (1 paper), interferon and immune responses (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Infectious Diseases (113 citations), Cancer Research (81 citations), Hepatology (29 citations), Pulmonary and Respiratory Medicine (93 citations) and Immunology (60 citations). Junfeng Hao has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Qin Ma, Taotao Wei, Yaping Tu, Peter W. Abel, Yan Xie, Linghai Li, Dennis W. Wolff, Peng Wei, Fayun Zhang and Wenjuan Dong. Their work appears in journals such as Nature Communications, iScience, Scientific Reports, Cell Research and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.